Charles Schwab’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.59M | Buy |
579,104
+57,843
| +11% | +$758K | ﹤0.01% | 2145 |
|
|
2025
Q1 | $11.5M | Sell |
521,261
-16,098
| -3% | -$354K | ﹤0.01% | 1891 |
|
|
2024
Q4 | $14.3M | Buy |
537,359
+15,273
| +3% | +$408K | ﹤0.01% | 1859 |
|
|
2024
Q3 | $13.9M | Sell |
522,086
-49,111
| -9% | -$1.31M | ﹤0.01% | 1884 |
|
|
2024
Q2 | $10.3M | Buy |
571,197
+74,035
| +15% | +$1.33M | ﹤0.01% | 2037 |
|
|
2024
Q1 | $9.07M | Buy |
497,162
+166,103
| +50% | +$3.03M | ﹤0.01% | 2031 |
|
|
2023
Q4 | $3.62M | Buy |
331,059
+200
| +0.1% | +$2.19K | ﹤0.01% | 2443 |
|
|
2023
Q3 | $1.9M | Buy |
330,859
+19,987
| +6% | +$115K | ﹤0.01% | 2615 |
|
|
2023
Q2 | $2.41M | Buy |
310,872
+16,561
| +6% | +$128K | ﹤0.01% | 2494 |
|
|
2023
Q1 | $1.96M | Sell |
294,311
-2,564
| -0.9% | -$17.1K | ﹤0.01% | 2526 |
|
|
2022
Q4 | $2.65M | Buy |
296,875
+94,102
| +46% | +$841K | ﹤0.01% | 2472 |
|
|
2022
Q3 | $2M | Buy |
202,773
+87,521
| +76% | +$862K | ﹤0.01% | 2585 |
|
|
2022
Q2 | $918K | Sell |
115,252
-30,053
| -21% | -$239K | ﹤0.01% | 2830 |
|
|
2022
Q1 | $1.41M | Buy |
145,305
+4,910
| +3% | +$47.6K | ﹤0.01% | 2744 |
|
|
2021
Q4 | $2.15M | Buy |
140,395
+56,285
| +67% | +$860K | ﹤0.01% | 2687 |
|
|
2021
Q3 | $1.4M | Buy |
84,110
+3,036
| +4% | +$50.4K | ﹤0.01% | 2771 |
|
|
2021
Q2 | $1.73M | Buy |
+81,074
| New | +$1.73M | ﹤0.01% | 2761 |
|